Peptides in Skin Care: What the Research Actually Shows

Signal peptides are designed to mimic the fragments that act as feedback signals when the skin makes matrix proteins such as collagen. The best-known example starts with a 1993 cell study: the five-amino-acid sequence KTTKS, a piece of the type I procollagen propeptide, was the minimum sequence needed to stimulate collagen and fibronectin production in cultured fibroblasts and other mesenchymal cells.^[3][2]

Attaching a palmitoyl fatty-acid chain turned KTTKS into palmitoyl pentapeptide-4 (pal-KTTKS), known by the trade name Matrixyl; the lipid tail is meant to improve delivery across skin and stability against skin enzymes. In a 12-week, double-blind, placebo-controlled split-face study of 93 women aged 35 to 55, a moisturiser containing pal-KTTKS reduced wrinkles and fine lines more than the same moisturiser without it, as measured by image analysis and expert graders.^[2][4]

That is a genuine controlled result, but it is one 12-week trial with a cosmetic endpoint. It does not show how long any effect lasts, and wrinkle measurements on the surface are not the same thing as measured changes in the skin's collagen.^[4]

Neurotransmitter-inhibitor peptides target the nerve signal behind expression lines. Acetyl hexapeptide-3, known by the trade name Argireline, is the sequence Ac-EEMQRR-NH2, designed to mimic the N-terminal end of the protein SNAP-25. In laboratory tests it interfered with the SNARE protein complex that nerve cells need to release neurotransmitters.^[5][6][2]

The original 2002 paper reported that an emulsion containing the hexapeptide reduced wrinkle depth by up to 30% after 30 days in healthy women. It found the peptide's potency in inhibiting neurotransmitter release similar to that of botulinum neurotoxin A, but its efficacy much lower. A 2013 randomised, placebo-controlled study of 60 Chinese participants reported reduced roughness of the wrinkles around the eyes after four weeks, compared with no change on placebo.^[5][6]

Neither study makes argireline a topical equivalent of botulinum toxin treatment. The first found far lower efficacy than the toxin, and both were short studies measuring surface wrinkles.^[5][6]

Carrier peptides deliver trace elements such as copper. The main example is copper tripeptide-1, the copper complex of the tripeptide GHK, which has an affinity for copper(II) ions. In fibroblast cultures, GHK-Cu stimulated collagen synthesis at very low concentrations.^[2][7]

Clinical evidence is much thinner than the cell data. In a small randomised trial on skin resurfaced with a CO2 laser, 13 patients completed the study; GHK-Cu skin care made no objective difference to redness, wrinkles or overall skin quality, although satisfaction was higher among the patients who used it.^[8]

Penetration is the central problem for skincare peptides. The skin's outer layer is an effective barrier, and a widely cited rule of thumb holds that a compound generally needs a molecular weight under about 500 daltons to be absorbed through it.^[9]

A 2022 review concluded that most anti-wrinkle peptides are poor candidates for skin permeation: they tend to be large, water-loving and electrically charged, and skin enzymes can break them down. Fatty-acid chains, penetration enhancers, microneedles and nano-carriers can raise permeation, but the review warned that many peptides may not reach their targets in the skin at the right concentrations without such help.^[10]

Copper peptide shows the problem in miniature. Copper applied as GHK-Cu crossed dermatomed human skin over 48 hours in a diffusion-cell study, yet another study found almost no peptide or copper passing intact human skin within nine hours unless the skin had been pretreated with microneedles.^[11][12]

The controlled trials that exist are small and short, running from about four weeks to three months, and they measure surface outcomes: wrinkle depth, skin roughness on silicone replicas, or expert grading of facial images.^[4][6][5]

For some newer peptides there is less than that. A 2020 review of cosmetic peptides noted ingredients whose only efficacy data came from the manufacturer, and others with no published clinical studies at all, although they were already used in products on the market.^[2]

The 2009 review that set out the four-group classification focused on controlled ex vivo and in vivo efficacy studies. For a reader, the useful question about any peptide product is whether such a study used that exact peptide, in a comparable formula, and measured the outcome being claimed.^[1]

In the EU, a peptide serum is a cosmetic product: a substance or mixture intended for the external parts of the body with a view exclusively or mainly to cleaning, perfuming, changing the appearance of, protecting or keeping them in good condition. Regulation (EC) No 1223/2009 also requires that cosmetic claims do not imply characteristics or functions a product does not have.^[13]

Research-grade peptides are a different category. Peptyds supplies GHK-Cu as a lyophilised research compound for laboratory research, with a batch certificate for identity and purity. A research compound is not a finished cosmetic product, and nothing on this page is guidance for personal use.